June 03, 2026
AABB is accepting questions for the "Ask the FDA and CMS/CLIA" session at the 2026 AABB Annual Meeting. This popular session provides an opportunity for attendees to submit questions to representatives from FDA and CMS/CLIA regarding the agencies' current thinking on policies, regulations, guidance documents and inspection programs relevant to the oversight of blood and biotherapies.
When submitting questions, individuals should identify the regulation or recommendation of interest, the specific issue or concern and any relevant background information.
The submission deadline is Friday, Aug. 7. Only questions submitted by the deadline will be considered.